Strength
.8 mg/1
Manufacturer
Avvisto Therapeutics LLCNDC
73515012330
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
BROMOCRIPTINE MESYLATEApproval Type
New Drug (NDA)
FDA Application
NDA020866On Market Since
5/23/2024
Pharmacological Classes
Ergolines
Ergot Derivative
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
No related drugs found.